Schedule 13G ownership disclosure
RECURSION PHARMACEUTICALS INC CL A
Common Stock · CUSIP: 75629V104
Event date: 2025-04-04
- Filing-level shares
- 267,500.00
- Percent of class
- 5.86%
- Yohan Kim
Shares: 267,500.00 · Class: 5.86%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-029096
- Form type
- SCHEDULE 13G
- Filer
- Kim Yohan
- CIK
- CIK 2063051
- Filed
- Apr 04, 2025
- Reporting period
- Apr 04, 2025
- Description
- Schedule 13G beneficial ownership